Edesa Biotech, Inc. Quarterly Common Stock, Shares, Issued from Q3 2013 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Edesa Biotech, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q3 2013 to Q2 2024.
  • Edesa Biotech, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 3.25M shares, a 84.4% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 3.25M -17.6M -84.4% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 3.22M -16.8M -84% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 3.16M -16.2M -83.6% Dec 31, 2023 10-Q 2024-02-09
Q3 2023 3.08M +695K +29.2% Sep 30, 2023 10-Q 2024-08-09
Q2 2023 20.9M +5.4M +35% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 20.1M +4.6M +29.7% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 19.4M +5.83M +43.2% Dec 31, 2022 10-Q 2023-02-10
Q3 2022 2.38M -10.9M -82.1% Sep 30, 2022 10-K 2023-12-15
Q2 2022 15.5M +2.21M +16.6% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 15.5M +2.22M +16.7% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 13.5M +3M +28.5% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 13.3M +3.68M +38.3% Sep 30, 2021 10-K 2022-12-16
Q2 2021 13.3M +4.39M +49.6% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 13.2M +4.39M +49.5% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 10.5M +3.02M +40.2% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 9.62M +2.11M +28.1% Sep 30, 2020 10-K 2021-12-28
Q2 2020 8.86M +1.36M +18.1% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 8.86M +3.53M +66.2% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 7.5M +4.26M +132% Dec 31, 2019 10-Q 2020-02-13
Q3 2019 7.5M +2.17M +40.8% Sep 30, 2019 10-K 2020-12-07
Q2 2019 7.5M +2.17M +40.8% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 5.33M +3.83M +255% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 3.24M -7.28M -69.2% Dec 31, 2018 10-KT 2019-12-12
Q3 2018 5.33M +3.83M +255% Sep 30, 2018 10-Q 2019-05-08
Q2 2018 5.33M -5.19M -49.3% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 1.5M -8.63M -85.2% Mar 31, 2018 10-Q 2018-05-07
Q4 2017 10.5M +384K +3.79% Dec 31, 2017 10-Q 2018-02-07
Q3 2017 1.5M -8.63M -85.2% Sep 30, 2017 10-K 2018-11-30
Q2 2017 10.5M +2.07M +24.5% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 10.1M +1.69M +20% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 10.1M +1.69M +20% Dec 31, 2016 10-Q 2017-02-06
Q3 2016 10.1M +2.15M +26.9% Sep 30, 2016 10-K 2017-12-01
Q2 2016 8.45M -71.1M -89.4% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 8.45M -71.1M -89.4% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 8.45M -71.1M -89.4% Dec 31, 2015 10-Q 2016-02-08
Q3 2015 7.98M +42.8K +0.54% Sep 30, 2015 10-K 2016-12-14
Q2 2015 79.5M Jun 30, 2015 10-Q 2015-08-10
Q1 2015 79.5M Mar 31, 2015 10-Q 2015-05-11
Q4 2014 79.5M Dec 31, 2014 10-Q 2015-02-09
Q3 2014 7.94M -50M -86.3% Sep 30, 2014 10-K 2015-12-14
Q3 2013 57.9M Aug 31, 2013 10-K/A 2014-11-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.